A drug that fights inflammation can reduce the risk of heart attacks and strokes, and possibly lung cancer, in people who have already had one heart attack and are at high risk for another, a new study finds.
Image courtesy of the New York Times.
Researchers outside the study say the findings represent a major milestone — proof of a biologic concept that opens the door to new ways of treating and preventing cardiovascular disease in people who are still at risk despite standard therapies.
But experts also cautioned that potentially fatal side effects of the drug, as well as its high cost, mean it is unlikely to be widely used. Cardiovascular disease is the leading cause of death worldwide and in the United States, where it killed nearly 634,000 people in 2015. Globally, it killed 15 million."